drugset / Trial / NCT00861978
St. John's Wort Extract LI 160 for the Treatment of Atypical Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of tis study is to assess the efficacy and safety of Jarsin® 300 mg as an acute treatment in mild to moderate depression with atypical features.
Timeline
- Start
- 2002-12
- Primary completion
- 2004-11
- Completion
- 2004-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | St Johns Wort Extract | Unknown | 300 mg | Oral |